Robuta

This phase II trial studies the effect of atezolizumab and cabozantinib in treating adolescents and young adults with osteosarcoma that has come back...

Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.

The targeted drug cabozantinib (Cabometyx) is effective for some people with papillary renal cell carcinoma (PRCC), a rare type of kidney cancer. In a clinical...

Cabozantinib s-malate is under clinical development by Exelixis and currently in Phase II for Colorectal Cancer.

Among patients with previously treated advanced hepatocellular carcinoma, treatment with cabozantinib resulted in longer overall survival and progression-free...